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Background and importance Different factors can influence the compatibility and stability of 
the mixture: drug type, concentration, solvent, container, temperature and light. There are 
some mixtures of drugs with proven stability, but there is a lack of evidence about the stability 
and compatibility of the combination of ondansetron and midazolam. The objective of this 
investigation was to study the compatibility and stability of a binary mixture of these drugs in 
solution for subcutaneous infusion in palliative care 
Aim and objectives To evaluate the compatibility and stability of two admixtures of 
ondansetron and midazolam at two different temperatures (25°C and 37°C). The 
concentrations of the admixtures were 0.1 g/L–0.1 g/L and 0.5 g/L–1.0 g/L in NaCl 0.9% stored 
in elastomeric infusors protected from light Material and methods Samples were prepared and 
diluted in NaCl 0.9% in elastomeric infusors in triplicate to obtain four different conditions of 
concentration and/or storage temperature (0.1 g/L–0.1 g/L; 0.5 g/L–1.0 g/L for ondansetron 
and midazolam, respectively, stored at temperatures of 25°C and 37°C). The concentration of 
each drug was periodically determined using HPLC-UV and UV-Vis spectrophotometry methods 
in the analytical chemistry laboratory between February and June 2019. Conditions: C18 
column, mobile phase methanol: KH2PO40.05 M, adjusted to pH 3 with H3PO3 (60:40, v/v) 
delivered at a flow rate of 1.0 mL/min. The sample injection volume was 20 mL, and triplicate 
injections were performed for every sample. The signal was recorded over 14 min and the 
retention times were 4.1 min for ondansetron and 7.8 min for midazolam. Ondansetron and 
midazolam concentrations were determined at 254 nm. 
Results HPLC-UV and UV-Vis spectrophotometric methods gave the same results. The stability 
of the admixtures diluted in NaCl 0.9% were as follow: ondansetron–midazolam (0.1 mg/mL–
0.1 mg/mL and 0.5 mg/mL –1.0 mg/mL) were stable(retained >90% of their initial 
concentrations) for only 1 day at 25°C and 37°C, respectively 
Conclusion and relevance Recommended use is for a maximum of 1 day, at the concentrations 
evaluated; over time it tends to precipitate. Infuser conditioning decreases stability with 
respect to other conditioning materials, so other stability studies may not be extrapolated if 
stored under different conditions. 
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